1 |
Shoda, L. K., Kegerreis, K. A., Suarez, C. E., Mwangi, W., Knowles, D. P. and Brown, W. C. (2001) Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages. J. Leukoc. Biol. 70, 103-112.
|
2 |
Zhou, L. J., Schwarting, R., Smith, H. M. and Tedder, T. F. (1992) A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 149, 735-742.
|
3 |
Zhou, L. J. and Tedder, T. F. (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154, 3821-3835.
|
4 |
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263-1272.
DOI
ScienceOn
|
5 |
Zhou, L. J. and Tedder, T. F. (1996) CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 93, 2588-2592.
DOI
ScienceOn
|
6 |
Fujimoto, Y., Tu, L., Miller, A. S., Bock, C., Fujimoto, M., Doyle, C., Steeber, D. A. and Tedder, T. F. (2002) CD83 expression influences CD4+ T cell development in the thymus. Cell 108, 755-767.
DOI
ScienceOn
|
7 |
Breloer, M., Kretschmer, B., Luthje, K., Ehrlich, S., Ritter, U., Bickert, T., Steeg, C., Fillatreau, S., Hoehlig, K., Lampropoulou, V. and Fleischer, B. (2007) CD83 is a regulator of murine B cell function in vivo. Eur. J. Immunol. 37, 634-648.
DOI
ScienceOn
|
8 |
Luthje, K., Kretschmer, B., Fleischer, B. and Breloer, M. (2008) CD83 regulates splenic B cell maturation and peripheral B cell homeostasis. Int. Immunol. 20, 949-960.
DOI
ScienceOn
|
9 |
Kim, D., Rhee, J. W., Kwon, S., Kim, Y. E., Choi, S. Y., Park, J., Lee, Y. and Kwon, H. J. (2010) Enhancement of immunomodulatory activity by liposome-encapsulated natural phosphodiester bond CpG-DNA in a human B cell line. BMB Rep. 43, 250-256.
과학기술학회마을
DOI
ScienceOn
|
10 |
Jahrsdorfer, B., Hartmann, G., Racila, E., Jackson, W., Muhlenhoff, L., Meinhardt, G., Endres, S., Link, B. K., Krieg, A. M. and Weiner, G. J. (2001) CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J. Leukoc. Biol. 69, 81-88.
|
11 |
Hartmann, G., Weiner, G. J. and Krieg, A. M. (1999) CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 96, 9305-9312.
DOI
ScienceOn
|
12 |
Kadowaki, N., Antonenko, S. and Liu, Y. J. (2001) Distinct CpG DNA and polyinosinic-polycytidylic acid double- stranded RNA, respectively, stimulate CD11c-type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J. Immunol. 166, 2291-2295.
DOI
|
13 |
Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F. and Liu, Y. J. (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869.
DOI
ScienceOn
|
14 |
Janeway, Jr. C. A. and Medzhitov, R. (1998) Introduction: the role of innate immunity in the adaptive immune response. Semin. Immunol. 10, 349-350.
DOI
ScienceOn
|
15 |
Krieg, A. M. (2002) CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760.
DOI
ScienceOn
|
16 |
Kim, D., Kwon, S., Ahn, C. S., Lee, Y., Choi, S. Y., Park, J., Kwon, H. Y. and Kwon, H. J. (2011) Adjuvant effect of liposome-encapsulated natural phosphodiester CpG-DNA. BMB Rep. 44, 758-763.
과학기술학회마을
DOI
ScienceOn
|
17 |
Jiang, T., Zhao, H., Li, X. F., Deng, Y. Q., Liu, J., Xu, L. J., Han, J. F., Cao, R. Y., Qin, E. D. and Qin, C. F. (2011) CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model. Antiviral Res. 89, 124-126.
DOI
ScienceOn
|
18 |
Wong, J. P., Christopher, M. E., Viswanathan, S., Karpoff, N., Dai, X., Das, D., Sun, L. Q., Wang, M. and Salazar, A. M. (2009) Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Vaccine 27, 3481-3483.
DOI
ScienceOn
|
19 |
Aderem, A. and Ulevitch, R. J. (2000) Toll-like receptors in the induction of the innate immune response. Nature 406, 782-787.
DOI
ScienceOn
|
20 |
Anderson, K. V. (2000) Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12, 13-19.
DOI
ScienceOn
|
21 |
Akira, S., Uematsu, S. and Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
DOI
ScienceOn
|
22 |
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K. and Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
DOI
ScienceOn
|
23 |
Krieg, A. M. (2006) Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5, 471-484.
DOI
ScienceOn
|
24 |
Stacey, K. J., Sweet, M. J. and Hume, D. A. (1996) Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157, 2116-2122.
|
25 |
Yi, A. K. and Krieg, A. M. (1998) CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of and and sustained activation of nuclear factor- /c-Rel. J. Immunol. 160, 1240-1245.
|
26 |
Yi, A. K., Klinman, D. M., Martin, T. L., Matson, S. and Krieg, A. M. (1996) Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157, 5394-5402.
|